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THE FATE OF STEM CELL RESEARCH AND A
PROPOSAL FOR FUTURE LEGISLATIVE
REGULATION
Lauren Thuy Nguyen*
I. INTRODUCTION
Ever since human stem cells were first isolated in 1998,
the possible applications of stem cell research and the moral
issues surrounding such research have created much
controversy.' This conflict has played out on both the federal
and state levels. During the November 2004 elections, the
presidential candidates were divided on the issue, causing
voters to cross party lines on the basis of their views on stem
cell research alone.2 At the state level, California introduced
Proposition 71, a ballot initiative that proposed to allocate
three billion dollars to stem cell research.' Public figures
including Nancy Reagan, California Governor Arnold
Schwarzenegger, and Bill Gates advocated stem cell research,
while conservatives and the Catholic Church opposed such
research.4 Voters were caught between wanting to promote
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1. John Miller, Comment, A Call to Legal Arms: Bringing Embryonic Stem
Cell Therapies to Market, 13 ALB. L.J. SCI. & TECH. 555, 556 (2003).
2. Claudia Kalb & Debra Rosenberg, Stem Cell Division, NEWSWEEK, Oct.
25, 2004, at 43.
3. Carl T. Hall, A New Era for Stem-Cell Study, S.F. CHRON., Nov. 4, 2004,
at B1.
4. See Terri Somers, Prop. 71 Opens Tap for Stem-cell Studies, Oct. 8,
2004, SAN DIEGO UNION-TRIBUNE, at A-i; John M. Broder & Andrew Pollack,
Californians to Vote on Spending $3 Billion on Stem Cell Research, N.Y. TIMES,
Sept. 20, 2004, at A-1. Sixty-nine percent of Americans reportedly favor the
expansion of stem cell research. 109 CONG. REC. E1268 (2005) (statement of
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research that might save lives and the ethical issues of using
embryos for research.5
This comment will briefly describe the science behind
stem cell research and examine why human embryonic stem
cell research has been the subject of such heated debate.6
This comment will then explore current federal and state
stem cell research regulations and the impact that politics
has had on these regulations.7 Next, this comment will
address the tension between state and federal powers, and
the issue of federalism that arises upon attempts to regulate
stem cell research.' Finally, this comment will propose a
federal regulatory scheme designed to address the policy and
federalism issues raised by stem cell research.9
II. BACKGROUND
A. The Science Behind Human Embryonic Stem Cell
Research
Human embryonic stem cells are unique because they are
unspecialized, °  divide without limitation," and may
Rep. Betty McCollum). Stem cell research is supported by over 200 patient
groups, universities, and scientific societies, and is endorsed by more than
seventy-five national and local newspapers and eighty Nobel Laureates. Id.
5. See Kalb & Rosenberg, supra note 2, at 43.
6. See infra Part II.A-B.
7. See infra Part II.C.
8. See infra Parts III-IV.
9. See infra Part V.
10. See Nat'l Insts. of Health, Stem Cell Information: What are the unique
properties of all stem cells?, http://stemcells.nih.gov/info/basics/basics2.asp (last
visited Mar. 13, 2006) [hereinafter What are the unique properties of all stem
cells?]; see also NAT'L RESEARCH COUNCIL INST. OF MED. OF NAT'L ACADEMIES,
GUIDELINES FOR HUMAN EMBRYONIC STEM CELL RESEARCH 15 (2005), available
at http://darwin.nap.edu/books/0309096537/html. Human embryonic stem cells
are not committed to a distinct cell lineage. See What are the unique properties
of all stem cells?, supra. One of the fundamental properties of a stem cell is
that it lacks any tissue-specific structures that allow it to perform specialized
functions. Id. However, unspecialized stem cells can give rise to specialized
cells, including heart, muscle, blood, or nerve cells. Id.
11. See What are the unique properties of all stem cells?, supra note 10.
Stem cells are capable of dividing and renewing themselves for long periods of
time. Id. Unlike muscle, blood, or nerve cells, which do not normally replicate
themselves, stem cells may replicate many times and can yield millions of cells
in the laboratory. Id. If the resulting cells continue to be unspecialized, then
they are capable of long-term self-renewal. Id.
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differentiate into specific types of cells.12  Given these
properties, human embryonic stem cells have three potential
applications. First and foremost, stem cell technologies could
provide potential treatments or cures to more than 128
million Americans13 who suffer from Parkinson's disease,
diabetes, traumatic spinal cord injury, Purkinje cell
degeneration, Duchenne's muscular dystrophy, heart disease,
and vision or hearing loss. 1 4  The ability of stem cells to
differentiate into any of the body's specific cell types provides
hope that stem cells can be used to replace or repair
degenerated or damaged organs, heal ailing tissues, and fight
diseases.'5 Second, stem cells may revolutionize the testing
and screening of drugs.16 Medicinal drugs could be tested
directly against stem cell lines instead of on animals. 7 Third,
12. Id. When stem cells divide, they either remain stem cells or become
terminally differentiated (i.e., become a specific type of cell). W. Christopher
Matton & F. Scott Thomas, The Continuing Balance: Federal Regulation of
Biotechnology, 44 JURIMETRICS J. 283, 308 (2004). The stem cell's internal
signals are controlled by genes that carry coded instructions for all of the
structures and functions of the cell, while its differentiation is controlled by the
microenvironment. See What are the unique properties of all stem cells?, supra
note 10; see also NAT'L RESEARCH COUNCIL INST. OF MED. OF NAT'L ACADEMIES,
supra note 10, at 29-30. Scientists can change the microenvironment by
altering the chemical composition of the culture medium, altering the surface of
the culture dish, or modifying the cells by inserting specific genes. See Nat'l
Insts. of Health, Stem Cell Information: What are embryonic stem cells?,
httpJ/stemcells.nih.gov/info/basics/basics3.asp (last visited Mar. 13, 2006). In
the Petri dish, the cells multiply and produce millions of identical copies of
specialized stem cell lines. Kalb & Rosenberg, supra note 2, at 46.
13. Daniel Perry, Patients' Voices: The Powerful Sound in the Stem Cell
Debate, 287 SCIENCE 1423, 1423 (2000).
14. NAVL INSTS. OF HEALTH, STEM CELLS: SCIENTIFIC PROFRESS AND
FUTURE RESEARCH DIRECTIONS 16, available at
http://stemcells.nih.gov/staticresources/info/scireport/PDFs/fullrptstem.pdf.
15. Sean M. O'Connor, Intellectual Property Rights and Stem Cell Research:
Who Owns the Medical Breakthroughs?, 39 NEW ENG. L. REV. 665, 688 (2005).
16. Nat'l Insts. of Health, Stem Cell Information: What are the potential
uses of human stem cells and the obstacles that must be overcome before these
potential uses will be realized?, http://stemcells.nih.gov/info/basics/basics6.asp
(last visited Mar. 13, 2006). Currently, the possible side effects of medicinal
drugs are initially tested on animals. Simon B. Auerbach, Comment, Taking
Another Look at the Definition of an Embryo: President Bush's Criteria and the
Problematic Application of Federal Regulations to Human Embryonic Stem
Cells, 51 EMORY L.J. 1557, 1560-61 (2002). However, with the use of stem cells,
this initial step of animal testing could be bypassed. Id. Drugs could instead be
directly tested against a stem cell line that is developed to mimic the disease
process in humans. Id.
17. See Auerbach, supra note 16, at 1561.
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stem cells may help to improve scientists' comprehension of
how and why birth defects occur.'
There are three sources of human stem cells from which
the greatest number of undifferentiated cells can be
obtained. 9  The first of these sources is from in vitro
fertilization clinics. 20 Embryos from such clinics are donated
by couples who receive infertility treatment.2' Currently,
there are approximately 400,000 excess embryos frozen in
fertility clinics nationwide.2 2  Eighty-four percent of these
clinics regularly discard unwanted embryos by incineration.
23
Stem cells are also derived from five- to nine-week-old
embryos that are obtained through elective abortions.24
Researchers believe that cells derived from this source have
very similar properties to those obtained from in vitro
fertilization clinics.25
The third source from which stem cells are obtained is
cloned embryos, created by a process called somatic cell
nuclear transfer ("SCNT").26  Although human cloning has
largely been deemed unethical, this form of therapeutic
cloning has received considerable support from the scientific
community as a viable alternative source of stem cells.
18. See id. Through this research, scientists may be able to determine what
methods will likely reduce, or even eliminate, certain birth defects. See id.
19. See 1 NAT'L BIOETHICS ADVISORY COMM'N, ETHICAL ISSUES IN HUMAN
STEM CELL RESEARCH 9 (1999), available at
http://www.georgetown.edu/research/nrcbl/nbac/stemcell.pdf. Sources of stem
cells, aside from embryonic stem cells, include adult tissue and umbilical cord
blood. JUDITH A. JOHNSON & ERIN WILLIAMS, CONGRESSIONAL RESEARCH
SERVICE REPORT FOR CONGRESS, STEM CELL RESEARCH, at CRS-2 (2004),
available at http://www.fas.org/spp/civil/crs/RL31015.pdf. However, these stem
cells may not be as long-lived or capable of as many cell divisions as embryonic
stem cells. Id.
20. See 1 NAT'L BIOETHICS ADVISORY COMM'N, supra note 19, at 9.
21. Id. When couples choose in vitro fertilization, doctors typically fertilize
several eggs with sperm in a Petri dish and then implant the fertilized eggs into
the womb after they have matured for about five days. Id. at 17. If there are
extra fertilized eggs, doctors store the extra embryos and couples may either
choose to discard the embryos, donate them to other couples, or donate them for
research. See id. at 53.
22. Dan Vergano, Embryonic Imbroglio, USA TODAY, Oct. 27, 2004, at 6D
[hereinafter Vergano, Embryonic Imbroglio].
23. Id.
24. JOHNSON & WILLIAMS, supra note 19, at CRS-1.
25. See id.
26. Id.
27. Ella De Trizio & Christopher S. Brennan, The Business of Human
Embryonic Stem-Cell Research and an International Analysis of Relevant Laws,
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Grown from a patient's own DNA, the cells could potentially
regenerate damaged tissue without the risk of rejection by
the patient's immune system. 28 Moreover, SCNT would allow
scientists to determine which genes trigger diseases, rather
than working backwards to figure out how a patient
contracted a disease.29
When an embryo is allowed to grow for five to six days, it
develops into a blastocyst.30 At the blastocyst stage, the outer
layer is partially differentiated and the inner layer is
composed of thirty to thirty-four undifferentiated stem cells. 1
The focus of stem cell research is to remove and study the
inner mass of undifferentiated cells.2 The ethical controversy
usually arises from this removal of undifferentiated cells from
the blastocyst because it terminates the life functions of the
embryo.3
B. Central Ethical Issues Surrounding Stem Cell Research
The two primary ethical dilemmas of stem cell research
revolve around the assessment of when human life begins and
the use of human embryos as research subjects. 4 To resolve
these dilemmas, numerous lawmakers, scientists,
commissions, and presidents have attempted to balance the
potential life of a human embryo with the possibility of
alleviating the suffering of millions of Americans. 5
7 J. BIOLAw & Bus. 4, 12 (2004), available at www.biolawbusiness.com (follow
the quick link to Volume 7, Number 4; then follow the hyperlink to the Trizio &
Brennan article). To produce these stem cells, scientists extract DNA from a
patient and fuse it with a hollowed-out egg cell. See 1 NAT'L BIOETHICS
ADVISORY COMM'N, supra note 19, at 20. The egg then grows into an embryo
that is a genetic replica of the donor's DNA. See id. Stem cells are then
extracted from the embryo. Id.
28. See 1 NAT'L BIOETHICS ADVISORY COMM'N, supra note 19, at 20.
29. Claudia Kalb, Welcome to the Stem-Cell States, NEWSWEEK, Dec. 6,
2004, at 52.
30. Margaret R. McLean, What's in a Name? "Nuclear Transplantation" and
the Ethics of Stem Cell Research, 53 HASTINGS L.J. 1017, 1023 (2002).
31. Id. at 1023-24.
32. See id. at 1024.
33. Nelle S. Paegel, Use of Stem Cells in Biotechnology Research, 22
WHITHrIER L. REV. 1183, 1186 (2001).
34. See 1 NAT'L BIOETHICS ADVISORY COMM'N, supra note 19, at 66; see
generally Charity Schiller, Comment, Stem-Cell Research and Conditional
Federal Funding: Do State Laws Allowing More Extensive Research Pose a
Problem for Federalism?, 31 PEPP. L. REV. 1017, 1031 (May 2004).
35. See 1 NAT'L BIOETHICS ADVISORY COMM'N, supra note 19, at xi.
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To address these concerns, President Bill Clinton issued
Executive Order 12,975 in 1995, which created the National
Bioethics Advisory Commission ("NBAC").36 According to
NBAC's executive summary, the commission recognized that
human embryos deserved respect as a form of human life.'
However, the commission disagreed over what form such
respect should take and what level of protection was required
at different stages of embryonic development. 3  NBAC
recognized that those who believe an embryo is a person from
the moment of conception would view research that destroyed
the embryo as wrong and impermissible.39 On the other
hand, NBAC acknowledged that arriving at an ethically
acceptable policy would require balancing a number of
important ethical concerns, such as the potential to cure
human disease, protecting human life, determining when
human life begins, and according human embryos the respect
they deserve.4 ° After assessing these ethical issues, NBAC
recommended that the federal government fund research if
the embryos were derived from fertility clinics, but not if they
were created through in vitro fertilization solely for research
purposes or derived from SCNT.4'
Subsequently, NBAC's recommendation fell into disfavor
after the change in administration in 2001. In August 2001,
President George W. Bush made a radio address to the
American public announcing his administration's position on
stem cell research.42 President Bush stated that stem cell
research was at the "leading edge of a series of moral
hazards. "4 He framed the ethical issues surrounding stem
cell research as "forc[ing] us to confront fundamental
questions about the beginnings of life and the ends of science.
[Stem cell research] lies at a difficult moral intersection,
36. Exec. Order No. 12,975, 60 Fed. Reg. 52063, 52063-65 (Oct. 3, 1995).
37. 1 NAT'L BIOETHICS ADVISORY COMM'N, supra note 19, at 66.
38. See id.
39. See id.
40. See id.
41. See id. at 68-69. The Commission concluded that somatic nuclear
transfer technology should not be granted federal funds because issues would
arise over the question of life. Id.
42. President George W. Bush, President Discusses Stem Cell Research
(Aug. 9, 2001), http://www.whitehouse.gov/news/releases/2001/08/20010809-
2.html (last visited Mar. 13, 2006).
43. Id.
424 [Vol: 46
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juxtaposing the need to protect life in all its phases with the
prospect of saving and improving life in all its stages."44
Moreover, President Bush declared that, "[w]e do not end
some lives for the medical benefit of others. For me, this is a
matter of conviction: a belief that life, including early life, is
biologically human, genetically distinct and valuable. 45 With
these ethical considerations in mind, President Bush decided
to limit federal funding of stem cell research only to those
stem cell lines already in existence. 46  He articulated his
commitment to the pursuit of stem cell research without
crossing a fundamental moral line by providing taxpayer
funding that sanctions or encourages further destruction of
human embryos.47
C. Stem Cell Research Regulations
1. Federal Executive Regulation
In 1999, the National Institutes of Health ("NIH") issued
guidelines48 that supported the use of federal funds for the
creation and research of stem cells from existing spare human
embryos, beyond the existing and recognized lines of
embryonic stem cells. 49 The guidelines were not regulations
that were mandated by federal law. ° However, compliance
was required for researchers to receive federal grants.5'
In 2001, President Bush rejected the NIH guidelines in
44. Id.
45. THE PRESIDENT'S COUNCIL ON BIOETHICS, MONITORING STEM CELL
RESEARCH 31-32 (2004) (quoting George W. Bush, Stem Cell Science and the
Preservation of Life, N.Y. TIMES, Aug. 12, 2001, at D13), available at
http://bioethics.gov/reports/stemcell/pcbe-final-version-monitoring-stem-cell-re
search.pdf.
46. Id. at41.
47. See Press Release, U.S. Dep't of Health & Human Servs., Embryonic
Stem Cell Research (Jul. 14, 2004), available at
http://www.hhs.gov/news/press/2004pres/20040714b.html.
48. The NIH developed a draft of the guidelines in December 1999. See
Draft National Institutes of Health Guidelines for Research Involving Human
Pluripotent Stem Cells, 64 Fed. Reg. 67,576 (Dec. 2, 1999).
49. Christopher W. Matton & F. Scott Thomas, The Continuing Balance:
Federal Regulation of Biotechnology, 44 JURIMETRICS J. 283, 309 (2004); see
JOHNSON & WILLIAMS, supra note 19, at CRS-6.
50. National Institutes of Health Guidelines for Research Using Human
Pluripotent Stem Cells, 65 Fed. Reg. 51,976 (Aug. 25, 2000) (corrected by 65
Fed. Reg. 69,951 (Nov. 21, 2000)).
51. Id.
425
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his radio address to the nation.52 He instead decided that
federal funds could be used for research on existing human
embryonic stem cell lines if, prior to his announcement: (1)
the derivation process, involving the removal of the inner cell
mass from the blastocyst, had already begun, and (2) the
embryo could no longer develop into a human being.53
Furthermore, consistent with the President's statements, the
Bush Administration limited federal funding to research on
certain existing stem cell lines. These stem cell lines were
obtained with the informed consent of the donors, derived
from excess embryos created solely for reproductive purposes,
and obtained without any financial inducements to the
donors .
President Bush has kept his promise to allocate federal
funding for stem cell research.55  In 2003, the federal
government provided $24.8 million for human embryonic
stem cell research.56 The Bush Administration also provided
$190.7 million for research on human non-embryonic stem
cells, which included research on adult stem cells derived
from cord blood, placenta, and bone marrow.
2. Congressional Regulation
a. Congress's Authority to Regulate Stem Cell
Research
As the head of the Executive Branch of the federal
government, the President of the United States has the final
responsibility and authority to set federal governmental
policy for the funding of human embryonic stem cell
research.58 Nevertheless, according to the U.S. Constitution,
52. President George W. Bush, Radio Address by the President to the
Nation (Aug. 11, 2001),
http'//www.whitehouse.gov/news/releases/2001/08/20010811-1.html (last visited
Mar. 13, 2006). See Matton & Thomas, supra note 49, at 309.
53. Press Release, The White House, Fact Sheet: Embryonic Stem Cell
Research (Aug. 9, 2001), available at
http'//www.whitehouse.gov/news/releases/2001/08/20010809-1.html.
54. See id.
55. Press Release, U.S. Dep't of Health & Human Servs., Embryonic Stem
Cell Research, supra note 47.
56. Id.
57. Id.
58. Nat'l Insts. of Health, Stem Cell Information, Frequently Asked
Questions, http'J/stemcells.nih.gov/info/faqs.asp [hereinafter Stem Cell
426 [Vol: 46
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the duty of federal lawmaking rests squarely on the shoulders
of Congress.5 9 Therefore, Congress arguably has authority to
override the President's policies.6" However, Congress may
only act if the Constitution expressly grants such authority.
61
In the context of stem cell research, Congress may be able to
exercise legislative power through the Commerce Clause and
the Spending Clause. The policies enacted pursuant to these
powers may also preempt state regulations because of the
Supremacy Clause.
i. Authority Under the Commerce Clause
Congress has the enumerated power to pass legislation
under the Commerce Clause. Article I, Section 8 of the U.S.
Constitution states: "Congress shall have the power to .. .
regulate commerce with foreign nations, and among the
several states, and with the Indian Tribes."62 The U.S.
Supreme Court has determined that congressional
regulations may fall within the purview of the Commerce
Clause if the subject of regulation is (1) an instrumentality of
interstate commerce, (2) a channel of interstate commerce, or
(3) an activity that has a substantial effect on interstate
commerce. 63 In order to have a substantial effect, the activity
should be commercial and should have an economic impact on
interstate commerce. 64
In Gonzales v. Raich, the U.S. Supreme Court found that
Information, FAQ] (follow "Does NIH fund embryonic stem cell research?"
hyperlink) (last visited Mar. 13, 2006). The National Institutes of Health is a
part of the executive branch. Id. The day-to-day enforcement and
administration of federal laws rests with various executive departments, such
as the Department of Health & Human Services, which administers the NIH.
These departments were created by Congress to govern specific areas of
national affairs. See U.S. DEPT. OF STATE, OUTLINE OF U.S. GOVERNMENT,
httpJ/usinfo.state.gov/products/pubs/outusgov/ch3.htm (last visited Mar. 13,
2006).
59. See Schiller, supra note 34, at 1048.
60. Stem Cell Information, FAQ, supra note 58 (follow "Who is responsible
for setting the policy to allow federal money to be used for human embryonic
stem cell research?" hyperlink) (last visited Mar. 13, 2006).
61. See United States v. Morrison, 529 U.S. 598, 607 (2000) ("Every law
enacted by Congress must be based on one or more of its powers enumerated in
the Constitution."); ERWIN CHEMERINSKY, CONSTITUTIONAL LAW PRINCIPLES
AND POLICIES 230 (2d ed. 2002).
62. U.S. CONST. art. I, § 8.
63. United States v. Lopez, 514 U.S. 549, 558-59 (1995).
64. Morrison, 529 U.S. at 610; see CHEMERINSKY, supra note 61, at 263.
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even if an activity is local, and though it may not be regarded
as commercial, it may still be regulated by Congress "if it
exerts a substantial economic effect on interstate
commerce."65 Thus, when Congress decides that the collective
effects of a certain activity pose a threat to the national
market, it may regulate the entire class of that activity.66
Although the U.S. Supreme Court has narrowed the
scope of Congress's commerce power by reviving the Tenth
Amendment as a limitation on federal authority, the
Commerce Clause remains the constitutional basis for a
broad array of federal legislation .6  The Tenth Amendment to
the U.S. Constitution protects state sovereignty from
improper federal intrusion.6  The Tenth Amendment states,
"[t]he powers not delegated to the United States by the
Constitution, nor prohibited by it to the States, are reserved
to the States respectively, or to the people."69 Traditionally,
states retain the police power to regulate matters that
concern their general welfare.7 ° Thus, while Congress may
possess the powers necessary to enact legislation involving
stem cell research, the Tenth Amendment may limit the scope
of congressional authority to do so.
ii. Authority Under the Spending Clause
Congress may also have the ability to regulate federally
funded stem cell research through its spending power.71
Article I, Section 8 of the U.S. Constitution gives Congress
the power "to lay and collect taxes, duties, imposts and
excises, to pay the debts and provide for the common defense
and general welfare of the United States; but all duties,
imposts and excises shall be uniform throughout the United
65. Gonzales v. Raich, 125 S. Ct. 2195, 2205-06 (2005) (citing Wickard v.
Filburn, 317 U.S. 111, 125 (1942)).
66. Id.
67. CHEMERINSKY, supra note 61, at 238-39.
68. Id. at 305.
69. U.S. CONST. amend. X.
70. See United States v. Morrison, 529 U.S. 598, 619 n.8 (2000). By virtue
of the general police power over the health, welfare, and morals of citizens,
states enjoy wide latitude to legislate according to bioethical principles. See 0.
Carter Snead, The Pedagogical Significance of the Bush Stem Cell Policy: A
Window into Bioethical Regulation in the United States, 5 YALE J. HEALTH
POL'y L. & ETHICS 491, 498 (2005).
71. See Schiller, supra note 34, at 1048.
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States."72 Congress is given great discretion in exercising its
spending powers.73 Accordingly, Congress should have the
authority to fund stem cell research74 because it may be
considered a matter of "general welfare."75 Congress may also
condition a state's receipt of federal funds by withholding
such receipt if a state does not conform to a congressionally
advocated policy or rule.76 Congress has used its spending
power to set forth conditions for the receipt of federal funds,
even in areas where Congress might not be able to otherwise
regulate.77 The Supreme Court has recognized that "the
financial inducement offered by Congress might be so coercive
as to pass the point at which 'pressure turns into
compulsion.'78
iii. Preemption of State Law Through the Supremacy
Clause
Policies enacted pursuant to the Commerce and Spending
Clauses may also preempt state regulations through the
Supremacy Clause, found in Article VI of the Constitution.79
The Supremacy Clause provides that laws made by Congress
are the "supreme law of the land."' As the Supreme Court
declared, "[ulnder the Supremacy Clause, from which our pre-
emption doctrine is derived, 'any state law, however clearly
within a State's acknowledged power, which interferes with
or is contrary to federal law, must yield."'' 1 Accordingly, if
there is a conflict between federal and state law, the federal
72. U.S. CONST. art. I, § 8.
73. CHEMERINSKY, supra note 61, at 273 (quoting United States v. Butler,
297 U.S. 1 (1936)).
74. See Snead, supra note 70, at 498.
75. See Schiller, supra note 34, at 1045 (stating that "Congress has found
stem cell research to be a topic rife with ethical, moral and social concerns," and
thus "the general welfare requirement would almost certainly be met").
76. See id. at 1048 (evaluating Congress's powers to use conditioned federal
funding to regulate stem cell research and concluding that Congress would have
sufficient constitutional power to legislate stem cell research and its potentially
beneficial applications).
77. See CHEMERINSKY, supra note 61, at 273.
78. South Dakota v. Dole, 483 U.S. 203, 211 (1987) (quoting Steward Mach.
Co. v. Davis, 301 U.S. 548, 590 (1937)).
79. U.S. CONST. art. VI.
80. See CHEMERINSKY, supra note 61, at 376.
81. Felder v. Casey, 487 U.S. 131, 138 (1988) (quoting Free v. Bland, 369
U.S. 663, 666 (1962)).
429
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law controls and the state law is invalid.82 There are two
common situations where preemption occurs: when a federal
law expressly preempts a state law, and when preemption is
implied by a clear congressional intent to preempt state law.83
Even though no stem cell bill proposed in Congress has
expressly sought to preempt state law, without a clear
directive stating that federal law will not preempt state law,
implied preemption may still occur. Implied preemption may
be present in the stem cell context in two situations: (1) when
concurrent compliance with both a federal and a state
regulation is a physical impossibility,' and (2) when the state
law "stands as an obstacle to the accomplishment and
execution of the full purposes or objectives of Congress." 5
Even if Congress has authority to regulate stem cell
research, the President may use his veto power to hinder
Congress's efforts to circumvent his Executive Order. 6 The
tension between these two branches of government, along
with the tension between federal and state powers, has made
stem cell research an issue of ripe constitutional concern.
b. Legislative Activity
i. The Dickey Amendment
In 1996, Congress attached a rider 7 to the Department of
Health and Human Services ("DHHS") appropriations bill,
called the Dickey Amendment.8 This Amendment prohibits
82. CHEMERINSKY, supra note 61, at 376.
83. Id. The Supreme Court has identified three scenarios where implied
preemption occurs: (1) where the federal government extensively regulates an
area of law, (2) where there is conflict between federal and state law, and (3)
where the state law interferes with a federal objective. In practice, these types
of preemption often overlap. Id. at 378.
84. Fla. Lime & Avocado Growers, Inc. v. Paul, 373 U.S. 132, 142-43 (1963)
(stating that preemption will occur where compliance with both federal and
state regulations is physically impossible).
85. Hines v. Davidowitz, 312 U.S. 52, 67 (1941).
86. See Sheryl Gay Stolberg, In Rare Threat, Bush Vows Veto of Stem-cell
Bill, N.Y. TIMEs, May 21, 2005, at Al.
87. "The rider, an amendment originally introduced by Representative Jay
Dickey," was attached to legislation that affected NIH funding in 1996.
JOHNSON & WILLIAMS, supra note 19, at CRS-3.
88. Omnibus Consolidated and Emergency Supplemental Appropriations
Act, Pub. L. No. 105-277, 112 Stat. 2681 (1998) (termed the "Dickey
Amendment" because the rider was co-authored by U.S. Representative Jay
Dickey). See Am. Ass'n for the Advancement of Science, AAAS Policy Brief:
430 [Vol: 46
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the use of federal funds for research towards the creation of
human embryos and research in which human embryos are
destroyed, discarded, or knowingly subjected to risk of injury
or death. 9
The Dickey Amendment would seem to settle the
question of federal funding for human embryonic stem cell
research because obtaining stem cells for such research
requires the destruction of human embryos.9 ° However, the
DHHS announced, in what is now referred to as the Rabb
Memorandum, 91 that funding of embryonic stem cell research
is, in fact, legal because these cells do not meet the statutory,
medical, or biological definition of a human embryo. 92
Although the DHHS has stated that embryonic stem cell
research does not fall within the purview of the Dickey
Amendment,93 President Bush has affirmed his desire to
maintain "the spirit" of the Dickey Amendment.94
Accordingly, the President relied on the Dickey
Amendment to frame his current policy of allocating funding
to embryonic stem cell research for existing stem cell lines, as
it does not encourage or contribute to any future destruction
of human embryos.9"
ii. Current Legislative Activity
Although it is evident that Congress has been active in
Stem Cell Research, httpJ/www.aaas.org/spp/cstc/briefs/stemcells/index.shtml
(last visited Mar. 13, 2006).
89. H.R. 3061, 107th Cong. 510 (2001) (enacted).
90. THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 45, at 21.
91. Memorandum from Harriet S. Rabb to Harold Varmus, M.D., Federal
Funding for Research Involving Human Pluripotent Stem Cells (Jan. 15, 1999)
(on file with the Santa Clara Law Review).
92. See JOHNSON & WILLIAMS, supra note 19, at CRS-4. Human stem cells
are not and cannot develop into an organism; they lack the capacity to become
organisms even if they are transferred into a uterus. See 1 NAT'L BIOETHICS
ADVISORY COMM'N, supra note 19, at 1. The finding was based in part on the
determination by the DHHS that the statutory ban on human embryo research
defines an embryo as an organism that, when implanted in the uterus, is
capable of becoming a human. JOHNSON & WILLIAMS, supra note 19, at CRS-4.
93. See Am. Ass'n for the Advancement of Science, supra note 88..
94. THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 45, at 28.
President Bush has made a number of statements articulating his position that
nascent human life is deserving of protection and should not be violated. See,
e.g., George W. Bush, Stem Cell Science and the Preservation of Life, N.Y.
TIMES, Aug. 12, 2001, at D13.
95. See THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 45, at 196.
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debating issues concerning stem cell research and cloning, it
is equally clear that the House of Representatives and the
Senate are in a virtual deadlock over the acceptability of
funding this research.96 Of the seven bills involving stem cell
research introduced in the House of Representatives during
the 107th Congress, none gained approval.97
In April 2004, 206 bipartisan members of the House of
Representatives signed a letter urging President Bush to
allow the federal government to finance studies on embryos
left over from in vitro fertilization clinics.98 A month later,
fifty-eight senators sent a similar letter to the President
requesting that he relax federal restrictions on stem cell
research. 99
As of this comment, the 109th Congress is considering a
total of twelve pieces of legislation. 100 The issues being
considered include: the federal government's infringement of
state or private programs that fund embryonic stem cell
research, 1'0 the creation of a national cord blood stem cell
96. See Schiller, supra note 34, at 1035-36.
97. Ban on Human Cloning Act, H.R. 1260, 107th Cong. (2001); Human
Cloning Research Prohibition Act, H.R. 1372, 107th Cong. (2001); Human
Cloning Prohibition Act of 2001, H.R. 1608, 107th Cong. (2001); Human Cloning
Prohibition Act of 2001, H.R. 1644, 107th Cong. (2001); Cloning Prohibition Act
of 2001, H.R. 2172, 107th Cong. (2001); Human Cloning Prohibition Act of 2001,
H.R. 2505, 107th Cong. (2001); Cloning Prohibition Act of 2001, H.R. 2608,
107th Cong. (2001).
98. Letter from Members of the House of Representatives (Apr. 28, 2004),
available at http://www.house.gov/degette/news/releases/040428.pdf; see Vicki
Kemper, Reagan's Death May Stir Debate on Stem Cell Research, L.A. TIMES,
June 8, 2004, at A10.
99. See Kemper, supra note 98, at A10.
100. Cord Blood Stem Cell Act of 2005, H.R. 596, 109th Cong. (2005); Stem
Cell Research Investment Act of 2005, H.R. 1650, 109th Cong. (2005);
Expressing the Sense of the Congress That the Federal Government Should Not
Infringe on State or Private Programs That Fund Embryonic Stem Cell
Research, H.R. Con. Res. 166, 109th Cong. (2005); Joe Testaverde Adult Stem
Cell Research Act, H.R. 2541, 109th Cong. (2005); Stem Cell Replenishment Act
of 2005, H.R. 162, 109th Cong. (2005); Bone Marrow and Cord Blood Therapy
and Research Act of 2005, S. 1317, 109th Cong. (2005); Stem Cell Research
Enhancement Act of 2005, S. 471, 109th Cong. (2005); Respect for Life
Pluripotent Stem Cell Act of 2005, H.R. 3144, 109th Cong. (2005); Stem Cell
Therapeutic and Research Act of 2005, H.R. 2520, 109th Cong. (2005); Respect
for Life Embryonic Stem Cell Act of 2005, H.R. 2574, 109th Cong. (2005);
Human Cloning Ban and Stem Cell Research Protection Act of 2005, H.R. 1822,
109th Cong. (2005); Cures Can Be Found, H.R. 3444, 109th Cong. (2005).
101. H.R. Con. Res. 166.
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bank network and registry, 102 the allowance of a tax credit to
holders of stem cell research bonds,'0 3 the expansion of
activities under the NIH to include adult stem cell
research,104 the authorization of federal funds for research on
embryonic stem cells, irrespective of the date on which such
stem cells were derived, 10 5 and prohibition of human cloning
and protection of SCNT stem cell research.
10 6
The House of Representatives recently passed a bill
termed the "Stem Cell Research Enhancement Act of 2005."1°7
This bill would essentially override President Bush's
Executive Order by allowing federal funds to be used for stem
cell research regardless of the date on which the "derivation
process for such stem cells [was] initiated or completed."10 8
Nevertheless, President Bush has threatened to veto the bill
if it passes both houses of Congress. 10 9
3. State Regulation
The federal government lacks exclusive jurisdiction to
regulate stem cell research. 110  In fact, states have the
authority to enact laws that permit or limit human embryonic
stem cell research using state funds."' Unless Congress
passes a law that bans it, states may fund research that uses
human embryonic stem cell lines that would be ineligible for
federal funding." 2 Some states have already banned,"' or are
102. H.R. 596; S. 681.
103. H.R. 1650.
104. Joe Testaverde Adult Stem Cell Research Act of 2005, H.R. 2541, 109th
Cong. (2005).
105. H.R. 162.
106. Human Cloning Ban and Stem Cell Research Protection Act of 2005,
H.R. 1822, 109th Cong. (2005); Human Cloning Ban and Stem Cell Research
Protection Act of 2005, S. 876, 109th Cong. (2005).
107. H.R. 810, 109th Cong. (2005). The House approved the bill by a 238 to
194 vote, with fifty Republicans in favor. Sheryl Gay Stolberg, House Approves
a Stem Cell Bill Opposed by Bush, N.Y. TIMES, May 25, 2005, at Al. This falls
short of the two-thirds majority needed to override President Bush's threatened
veto. Id.
108. H.R. 810.
109. Marc Sandalow, Frist's Shift May Lead to Bush's First Veto; Bill to
Expand Stem Cell Research Headed for Passage, S.F. CHRON., July 30, 2005, at
A6.
110. See Stem Cell Information, FAQ, supra note 58 (follow "May individual
states pass laws to permit human embryonic stem cell research?" hyperlink)
(last visited Mar. 13, 2006).
111. Id.
112. Id.
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considering banning, the destruction of human embryonic
stem cells for research, 114 while other states have expressly
endorsed such research. Several states also have human
cloning laws that may impact stem cell research." 5
a. Stem Cell Research in California
California was the first state to enact legislation
encouraging stem cell research. 1 6  On September 22, 2002,
Governor Gray Davis signed into law a bill that sought to
protect stem cell research."17  This bill allows research on
stem cells that were derived from human embryonic stem
cells, human embryonic germ-cells, SCNT, and human adult
stem cells, regardless of whether the stem cell line existed at
the time of President Bush's Executive Order."1 8 The bill also
prohibits the purchase or sale of embryonic or cadaveric fetal
tissue. 19 Governor Davis subsequently signed several other
pieces of legislation related to stem cell research. These bills
establish ethical and legal standards that govern stem cell
research 20  and the disposition of human embryos for
individuals undergoing fertility treatment. 2 1
On November 2, 2004, fifty-nine percent of Californians
voted to approve the California Stem Cell Research and Cures
113. Aaron Zitner, States Challenge Bush on Embryonic Stem Cell Research,
L.A. TIMES, Nov. 29, 2002, at A32. In recent years, Iowa, Michigan, and
Virginia have banned cloning for any purpose, while Louisiana, Rhode Island,
and California banned cloning to initiate a pregnancy. Id. A handful of other
states have laws protecting embryos, which might be interpreted as barring
embryonic stem cell experiments. Id.
114. Dan Vergano, States Dive Into Stem Cell Debates, USA TODAY, Apr. 24,
2004, at 1D. Thirty-three state legislatures have considered 100 bills that
condemn, condone, or fund embryonic stem cell research. Id.
115. See Nat'l Conference of State Legislatures, State Human Cloning Laws,
httpJ/www.ncsl.org/programs/health/genetics/rt-shcl.htm (last visited Mar. 14,
2006). Fourteen states have laws pertaining to human cloning. See id.
116. See Jessica J. Monachello, Comment, The Cloning for Biomedical
Research Debate: Do the Promises of Medical Advances Outweigh the Ethical
Concerns?, 10 TULSA J. COMP. & IN'L L. 591, 604 (2003).
117. CAL. HEALTH & SAFETY CODE §§ 125115-125117 (2003) (current version
at CAL. HEALTH & SAFETY CODE §§ 125300-125320 (Deering Supp. 2006)); see
Carl Ingram, Gun, Stem Cell Bills Signed: Governor Davis Approves Measures
to Make Semiautomatic Pistols Safer and Advance Research on Serious
Diseases, L.A. TIMES, Sept. 25, 2003, at B1.
118. See CAL. HEALTH AND SAFETY CODE § 125300.
119. Id.
120. Id. § 125305.
121. Id. § 125315.
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Bond Act of 2004 (hereinafter referred to as the "Act"). 122 The
Act closes the funding gap created by the federal government
moratorium by establishing an institute that will issue bonds
to support stem cell research.123  It also authorizes an
allocation of three billion dollars in bonds, 124 distributed over
a ten-year period, to fund stem cell research and advanced
medical research facilities at California's universities and
throughout the state.1 25  The Act also expressly permits
research on adult stem cells, cord blood stem cells, progenitor
cells, and pluripotent stem cells derived from SCNT and in
vitro fertilization treatments.126
The Act establishes the California Institute for
Regenerative Medicine (CIRM), headquartered in San
Francisco. 127  The Act also creates an Independent Citizen's
Oversight Committee (ICOC), which will grant awards,
establish policies regarding intellectual property rights, and
develop annual and long-term strategic research and
financial plans for the institute. 28 The ICOC has taken the
position that the CIRM will focus its attention on financing
research opportunities that federal grants cannot assist.129
Specifically, the biggest emphasis would be on SCNT
research. 30 By far, the Act would create the largest state-run
scientific research effort in the country and make California
the global center of stem cell research, on par with Singapore,
Israel, South Korea, and the United Kingdom, all of which
122. See Megan Garvey, California Stem Cell Project Energizes Other States
to Act, L.A. TIMEs, Nov. 22, 2004, at Al; Carl T. Hall, Proposition 71: A New Era
for Stem-cell Study, S.F. CHRON., Nov. 4, 2004, at B1 [hereinafter Hall,
Proposition 711.
123. Hall, Proposition 71, supra note 122, at B1.
124. CAL. HEALTH & SAFETY CODE § 125291.30.
125. Id. § 125290.10.
126. CAL. CONST. art. XXXV §5.
127. CAL. HEALTH & SAFETY CODE §§ 125291.10-.85; see Cal. Inst. for
Regenerative Med., CIRM and SF Formalize Relationship: Newsom and Klein
Sign Agreement Certifying San Francisco's Bid (June 23, 2005),
http://www.cirm.ca.gov/pressreleases/2005/06/06-23-05.asp; see also Carolyn
Marshall, New Stem Cell Research Panel Chooses San Francisco as Home, N.Y.
TIMES, May 7, 2005, at All.
128. CAL. HEALTH & SAFETY CODE §§ 125290.10-.45.
129. See Carl T. Hall, Stem Cell Institute Awaits D.C. News; House Vote Seen
as Show of Support, S.F. CHRON., May 26, 2005, at B1 [hereinafter Hall, Stem
Cell Institute Awaits D.C. News].
130. Id.
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have moved aggressively in the field since the late 1990s.13 1
Several state legislators, however, have concerns about
the Act. 132 Senator Deborah Ortiz has advocated an
amendment to the California Constitution that would change
the ground rules for the Act by increasing public oversight
and ensuring that state-financed stem cell treatments are
affordable and accessible. 33 In response, the ICOC issued a
press release stating its opposition to the amendment and
that the amendment would make it extremely difficult, if not
impossible, for scientists to accomplish their work by delaying
the production of critically needed medical therapies.'
Meanwhile, another obstacle for issuing the stem cell bonds
has arisen from lawsuits filed by pro-life advocates who
challenge the destruction of human embryos for stem cell
research. 13
5
b. Stem Cell Research in New Jersey
New Jersey was the second state to endorse embryonic
stem cell research. 136 In response to the California initiative,
former New Jersey Governor Richard Codey committed $150
million in state funds to build a stem cell research center. 137
Codey's successor, Governor James McGreevey, signed a bill
131. See John M. Broder & Andrew Pollack, Californians to Vote on Spending
$3 Billon on Stem Cell Research, N.Y. TIMES, Sept. 20, 2004, at Al.
132. See Carl T. Hall, State's Stem Cell Board Opposes Proposal for Increased
Oversight, S.F. CHRON., June 7, 2005, at B8.
133. Resolution to propose an amendment to the Constitution by amending
section 6, relating to biomedical research, S. 13, 2005 Leg., Reg. Sess. (Cal.
2005).
134. Press Release, Cal. Inst. for Regenerative Med., ICOC Takes a Stand on
Pending State and Federal Legislation on Stem Cell Research: Board Votes to
Oppose Ortiz/Runner (SCA 13) and to Support Castle/DeGette (HR 810) (May
23, 2005), available at http://www.cirm.ca.gov/pressreleases/2005/05/05-23-
05.asp.
135. Cal. Healthcare Inst., Sacramento at a Glance: Vote Not Likely on Stem
Cell Policies, http://www.chi.org/home/article.php?pid=949 (last visited Feb. 28,
2006). The pro-life advocates filed their lawsuit against the ICOC members and
other state officials in June 2005. See id. They sought to have human embryos
declared persons with constitutional rights. Id. The two lawsuits have created
a major roadblock for the stem cell program because the proposition will lack
investor support until the legal questions are settled. Andrew Pollack, A
California Ruling Sends 2 Stem Cell Suits to Trial, N.Y. TIMES, Dec. 1, 2005, at
C-9.
136. Garvey, supra note 122, at Al.
137. John Sullivan, Codey to Seek Ethics Panel on Stem Cells, N.Y. TIMES,
Apr. 15, 2005, at B7.
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in May 2004 to establish the nation's first state-sponsored
stem cell research institute,3 8 a $25 million endeavor. 3 9 New
Jersey currently permits research involving the derivation
and use of human embryonic stem cells, human embryonic
germ cells, human adult stem cells, and SCNT. 40 New Jersey
law requires the physician or other health care provider
treating a patient for infertility to provide the patient with
information sufficient to allow that person to make an
informed and voluntary choice about the disposition of any
embryos created during the patient's treatment.14 1 A person
who elects to donate embryos for research purposes
remaining after infertility treatments is required to provide
written consent to that donation.
4 2
As states such as California and New Jersey race forward
in the stem cell industry, many other states are considering
similar legislation in order to remain competitive. 4 3 States
recognize that stem cell research is an important emerging
field of biology and, thus, believe that this new industry could
generate well-paying jobs as well as cures for disease."
However, state legislatures recognize that although national
polls show that seven out of ten voters support the idea of
stem cell research, the moral debate over using human
embryos makes the subject politically controversial. 45
Given the recent spur of activity over stem cell research
at both the federal and state level, the question of which level
of government is better suited to regulate stem cell research
is certain to arise. The next section will introduce this legal
problem.
III. IDENTIFICATION OF THE LEGAL PROBLEM
Stem cell research is a topic full of ethical and political
138. David Kocieniewski, McGreevey Signs Bill Creating Stem Cell Research
Center, N.Y. TIMES, May 13, 2004, at B5.
139. JOHNSON & WILLIAMS, supra note 19, at CRS-14.
140. See id.
141. N.J. STAT. ANN. § 26:2Z-2 (West Supp. 2005).
142. Id.
143. See John Chase & Peter Gorner, Stem-cell Question May Land on Ballot;
Plan to Let Voters Decide in 2006, CHi. TRIB., Nov. 24, 2004, at Ml; Garvey,
supra note 122, at Al; Laura Mansnerus, New Jersey Faces Tough Competition
for Stem Cell Scientists, N.Y. TIMES, Jan. 17, 2005, at B1.
144. See Garvey, supra note 122, at Al.
145. Id.
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controversies. The state and federal governments have
attempted to regulate this area of research since its discovery.
Thus far, Congress has remained silent on the issue, while
President Bush has limited the funding of stem cell research
by Executive Order. Meanwhile, a number of states have
restricted such research, while others have funded and
expanded the science. Because the state and federal
governments have enacted an inconsistent regulatory scheme
for stem cell research, problems of federalism will arise if and
when Congress chooses to speak on this issue. In particular,
there is a question of whether Congress has the constitutional
authority to regulate stem cell research. Further, if it does
have such authority, a larger problem of preemption and the
content of such federal regulation arises.
IV. ANALYSIS
A. Congress's Ability to Enact Stem Cell Research Legislation
1. Congressional Power Under the Commerce Clause
Although President Bush used an Executive Order to
institute a national policy on stem cell research, 146 under the
U.S. Constitution, the duty of federal lawmaking rests
squarely on the shoulders of Congress. 147  Pursuant to the
Commerce Clause, Congress may have the power to regulate
public and private stem cell research. Congressional
regulations may be considered to fall within the purview of
the Commerce Clause if the subject of the regulation is an
instrumentality or channel of interstate commerce, or is an
activity that has a substantial effect on interstate
commerce. 148
Arguably, stem cell research has a substantial effect on
interstate commerce. It is firmly established that Congress
may regulate purely local activities that contribute to an
economic "class of activities" that have a substantial effect on
146. Tara L. Branum, President or King? The Use and Abuse of Executive
Orders in Modern-Day America, 28 J. LEGIS. 1, 45-47 (2002).
147. See Schiller, supra note 34, at 1049; see also Youngstown Sheet & Tube
Co. v. Sawyer, 343 U.S. 579, 587 (1952) ("In the framework of our Constitution,
the President's power to see that the laws are faithfully executed refutes the
idea that he is to be a lawmaker.").
148. United States v. Lopez, 514 U.S. 549, 558-59 (1995).
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interstate commerce.149 This "substantial effect" test is likely
satisfied in the case of stem cell research because such
research efforts will likely have a significant commercial and
economic impact throughout the country. Potentially
lucrative drug therapies based on stem cell research provide
one example of this economic effect. Moreover, the
biotechnology industry involved in the research and
production of stem cells is an increasingly considerable
segment of the U.S. economy. 150 The potential for such
research to lead to cures for pandemic diseases will have a
financial impact of millions, if not billions, of dollars for
private industries and educational institutions.1 51
In Gonzales v. Raich, the U.S. Supreme Court held that
Congress's authority under the Commerce Clause includes
the power to prohibit local cultivation and use of marijuana,
irrespective of such activities' legality under California law. 2
The issue before the U.S. Supreme Court surrounded the
growth of medical marijuana that was purported to be a
purely intrastate, noncommercial activity. 5 3  Respondents
also contended that the possession and use of medical
marijuana for personal medical purposes were in accordance
with state law.' Nevertheless, the Court found there existed
a "rational basis" for Congress's conclusion that private
growth and use of marijuana has a "substantial effect" on the
interstate commerce of drugs. 55 Like the growth and use of
marijuana in Raich, the aggregate growth and use of stem
cells by biotechnology companies may have a "substantial
effect" on the interstate commerce of this industry. Thus,
under the Court's Commerce Clause jurisprudence in Raich,
Congress likely has authority to regulate stem cell research
through its Commerce Clause power.
Given Congress's power to enact legislation regulating
149. See, e.g., Gonzales v. Raich, 125 S. Ct. 2195, 2205 (2005).
150. See Denise Stevens, Comment, Embryonic Stem Cell Research: Will
President Bush's Limitation on Federal Funding Put the United States at a
Disadvantage? A Comparison Between U.S. and International Law, 25 HOUS. J.
INT'L L. 623, 646-49 (2003).
151. See id. at 646.
152. Raich, 125 S. Ct. at 2209, 2212-13.
153. See id. at 2204-05.
154. Id.
155. Id.
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the commerce of stem cells,5 6 Congress should be able to
regulate both private sector and state activity over how stem
cells are derived, whether informed consent is necessary, and
how the stem cells are banked and distributed.
2. Preemption of State Regulation by Congress
Thus far, states have been unrestricted in regulating
their own research. However, if Congress effectively
exercises its power to regulate stem cell research, then the
Supremacy Clause would trigger the issue of preemption for
state-created stem cell research programs. 5 7  Such
preemption could nullify states' efforts to regulate and fund
stem cell research and could hinder progress that states have
made in this area.
There are two situations applicable to stem cell research
where preemption could occur. First, a federal law could
expressly preempt a state law.15 8 Second, preemption could
be implied by clear congressional intent to preempt a state
law.
15 9
With respect to the first type of preemption, the House of
Representatives has already proposed a concurrent
resolution,16  which provides that the federal government
156. See, e.g., Human Cloning Prohibition Act of 2005, S. 658, 109th Cong.
(2005); Human Cloning Prohibition Act of 2005, H.R. 1357, 109th Cong. (2005).
Congress declared in this bill that it has the authority to regulate cloning
because it affects stem cell research. See id. The bill provides:
It shall be unlawful for any person or entity, public or private, in or
affecting interstate commerce, knowingly -
(1) to perform or attempt to perform human cloning;
(2) to participate in an attempt to perform human cloning; or
(3) to ship or receive for any purpose an embryo produced by human
cloning or any product derived from such embryo.
Id. § 302(a)(1)-(3).
157. See U.S. CONST. art. VI, cl. 2. The Supremacy Clause provides that if
there is a conflict between a federal and a state law, then the federal law
controls and the state law is invalidated because the federal law is supreme.
CHEMERINSKY, supra note 61, at 376.
158. CHEMERINSKY, supra note 61, at 376.
159. Id. at 378.
160. Concurrent resolutions must be passed in the same form by both houses,
but they do not require the President's signature and are not legally binding.
U.S. Senate Legislation, Laws and Acts,
http://senate.gov/legislativelcommon/briefing/legiaws-acts.htm#3 (last visited
Dec. 22, 2005). Concurrent resolutions are generally used to make or amend
rules that apply to both houses of Congress. Id. They are also used to express
the sentiments of both of the houses. Id.
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should not infringe on state or private programs that fund
embryonic stem cell research. 16' However, this resolution by
itself will not resolve issues that remain due to a lack of
federal legislation in this field. First, concurrent resolutions
are not legally binding.'62 Second, the type of research
permitted varies by states. 63  Some states have expressly
endorsed stem cell research, while other states have
restricted such research. Thus, variations between states
regarding the breadth of research allowed will ultimately lead
researchers to migrate toward more favorable states. 64
Second, with regard to implied preemption, in the context
of stem cell research this could occur if a state allowing
research on SCNT stem cells were confronted with federal
legislation that bars experimentation on embryos derived
from cloning, including SCNT stem cells. 61 In that scenario,
states permitting SCNT would no longer be able to make
advancements using these means, as they would be illegal.
This problem is very real in the State of California, as the
ICOC has expressly stated that it endorses SCNT research.
66
Considering the great lengths that California has taken to
develop and fund legislation supporting stem cell research,
specifically SCNT research, federal legislation preempting
such investment may thwart any advancements made thus
far.
Preemption would thus have the effect of leveling the
playing field between the states. The generosity of funding
and the level of ethical and scientific regulation would vary
according to each state's constituencies and oversight
committees. Inevitably, from a business and economic
standpoint, states willing to give the most latitude will
attract the best researchers in the field because they will be
able to work with the most advanced technologies.' 67 This is
problematic because states would be disinclined to implement
strict moral guidelines and would instead mold their policies
161. See H.R. 2520 RDS, 109th Cong. (2005).
162. U.S. Senate Legislation, supra note 160.
163. See Stevens, supra note 150, at 652.
164. See id.
165. See, e.g., S. 658, 109th Cong. (2005); H.R. 1357, 109th Cong. (2005).
The bill prohibits human cloning, including SCNT. Id. § 498(D)(b)(1)-(3).
166. See Hall, Stem Cell Institute Awaits D.C. News, supra note 129, at B1.
167. See O'Connor, supra note 15, at 681.
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to meet researchers' demands.
As states like California create their own oversight
committees, ethical issues will be assessed within the
confines of an untested institution.1 6 8  This development
demonstrates the degree to which the federal government will
remain excluded from important developments in the stem
cell debate.'69 A redundancy in government bureaucracy will
be created since the NIH's purpose is to oversee such
research. 170  Implementation of a federal regulation that
empowers the NIH would ultimately streamline this entire
process.
B. Lack of Federal Legislation Regarding Stem Cell Research
Currently, there are no existing federal statutes or
related regulations that specifically address human stem cell
research.' 7 ' However, the federal government has created
guidelines for fetal research. 172 The guidelines set forth that:
The Secretary may not conduct or support any research or
experimentation, in the United States or in any other
country, on a nonviable living human fetus ex utero or a
living human fetus ex utero for whom viability has not
been ascertained unless the research or experimentation-
(1) may enhance the well-being or meet the health needs
of the fetus or enhance the probability of its survival to
viability; or (2) will pose no added risk of suffering, injury,
or death to the fetus and the purpose of the research or
experimentation is the development of important
biomedical knowledge which cannot be obtained by other
means. 1
73
The ethical debate as to when life actually begins arises
from the concept that a stem cell is considered a fetus under
this Act.174 If stem cells are considered fetuses, research may
168. Ryan Fujikawa, Note, Federal Funding of Human Embryonic Stem Cell
Research: an Institutional Examination, 78 S. CAL. L. REV. 1075, 1118-19
(2005).
169. Id. at 1119.
170. Id.
171. See Matton & Thomas, supra note 49, at 309-10.
172. 42 U.S.C. § 289g (2000).
173. Id. (emphasis added).
174. See, e.g., Roe v. Wade, 410 U.S. 113, 158 (1973) (determining that the
word "person," as used in the Fourteenth Amendment, does not include the
unborn).
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be conducted under this federal regulation only if an
exception applies. Accordingly, human embryonic stem cell
research may fall within the exception requiring that such
research offers biomedical knowledge that cannot be obtained
by other means. Given the forecasted medical advancements
in stem cell research, conducting research on stem cells
should not violate this federal regulation.
With this tension between state and federal regulation of
stem cell research, the bounds of federalism will surely be
tested. The federal government, using its aforementioned
powers, 15 will be able to set standards for stem cell research.
Given this trend, Congress should set a national policy that
will clearly guide both states and private industries as they
research using this technology. The next section of this
comment will propose such federal legislation.
V. PROPOSAL
Many academics 176  and policymakers recognize the
pressing need for a uniform national policy governing stem
cell research that extends beyond the efforts made by
individual states.177 Such a scheme would encourage stem
cell research because it would allow for greater certainty in
the industry. A federal regulation would normalize state
approaches to such research and would allow businesses to
operate more efficiently and without the threat of their
investments being abrogated by changes in state law. The
federal government has heavily regulated the biotechnology
industry since the mid-1970s,'17 and stem cell research should
not be treated any differently. Inconsistent legislation among
the states and the virtual lack of regulation in the private
175. See supra Part II.C.1.
176. As John Gearhart, a professor at Johns Hopkins, stated: "I believe
strongly we should have a national policy [for stem cell research] that permits
this work to go forward with appropriate oversight. But the fact is we don't
have it." Hall, Proposition 71, supra note 122, at B1.
177. NATL RESEARCH COUNCIL INST. OF MED. OF NAT'L ACADEMIES, supra
note 10, at 1. The National Academies panel said that uniform national
guidelines are needed to reassure the public that the research is being
conducted ethically, whatever the funding source, and to assure scientists of
reliable standards for conducting and sharing their work. Id.
178. Matton & Thomas, supra note 49, at 288. The Bush policy was written
against the backdrop of the nearly thirty-year history of give and take between
the executive and legislative branches over the question of federal funding for
embryo research. Snead, supra note 70, at 497.
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sector make it now more important than ever that the federal
government implement stem cell research policies that will
normalize the state and private industries in accordance with
the ethical, scientific, and social concerns of the country.179
Congress should set guidelines in five important areas of
concern regarding stem cell research: (1) procurement of stem
cells for research; (2) informed consent from individuals who
donate embryos and human tissue for research; (3)
registration of stem cells used for research; (4) regulation
standards for both private and public research, regardless of
whether the research is funded by the federal government;
and (5) guidelines expressly indicating that state regulations
are not entirely preempted by federal legislation.18 °
Under the first area of regulation, the legislature must
create standards for the procurement of stem cells used for
research. 81 Congress has tried numerous times to exclude
SCNT from this list because of the ethical implications of
using such research. 182 However, the use of SCNT technology
is necessary to advance stem cell technology.183  This
technology reduces the risk of rejection by the body of a
patient who receives stem cell treatment and allows scientists
to understand how diseases begin.' s4 Harvard University is
considering using such technology in its research. 85
179. See Stevens, supra note 150, at 652.
180. See National Institutes of Health Guidelines for Research Using Human
Pluripotent Stem cells, 65 Fed. Reg. 51,976 (Aug. 25, 2000). Guidelines were
changed after President Bush initiated his Executive Order on stem cell
research. See id. The proposed regulation is loosely based upon the NIH
guidelines published in 2000 and the guidelines set forth by the National
Academies. See id. The NIH's guidelines are considered to be "a source for a
wealth of insight into how federal regulations can, and perhaps in the future
will, be applied to human [embryonic stem] cell research." Auerbach, supra
note 16, at 1580.
181. See 65 Fed. Reg. at 51,976.
182. Human Cloning Research Prohibition Act, H.R. 222, 109th Cong. (2005);
Cloning Prohibition Act of 2003, H.R. 801, 108th Cong. (2003); Human Cloning
Research Prohibition Act, H.R. 916, 108th Cong. (2003); Human Cloning Ban
and Stem Cell Research Protection Act of 2003, S. 303, 108th Cong. (2003);
Human Cloning Prohibition Act of 2003, S. 245, 108th Cong. (2003); Human
Cloning Prohibition Act of 2003, H.R. 234, 108th Cong. (2003); Human Cloning
Prohibition Act of 2003, H.R. 534, 108th Cong. (2003) (as passed by the House of
Representatives, Feb. 27, 2003).
183. See McLean, supra note 30, at 1022-23.
184. Id.
185. See Joyce Howard Pierce, Stem Cell Ambivalence, WASH. TIMES, Jan. 9,
2005, at Al.
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Without the use of SCNT and human embryonic stem
cells, it would be impossible for researchers to compare the
advantages and effectiveness of such stem cells with adult
stem cells.1 86 Accordingly, the federal guidelines should allow
for research from the following sources: adult stem cells, cord
blood stem cells, progenitor cells, stem cells derived from
SCNT, and stem cells donated by individuals with excess
embryos from in vitro fertilization treatments.8 7 This new
standard would essentially render President Bush's
limitation of research to existing stem cell lines void, which is
well within Congress's lawmaking authority.'
The second part of the proposed guideline would require
consent from stem cell donors. Stem cells may be derived
from embryos, umbilical cords, and from embryos discarded
at infertility clinics.8 9 Thus, it is necessary to obtain consent
from individuals who intend to donate their embryo or tissue
for research. 90  It is important that the guidelines for
informed consent follow the national guidelines for
researchers set by the Institutional Review Board.' 9 ' Both
male and female donors should be required to sign a
statement agreeing to allow their excess embryos to be used
186. See 65 Fed. Reg. at 51,976.
187. See id. In response to criticism of using human pluripotent stem cells
for research, the NIH reasoned:
Given the enormous potential of stem cells to the development of new
therapies for the most devastating diseases, it is important to
simultaneously pursue all lines of promising research. It is possible
that no single source of stem cells is best or even suitable or ... usable
for all therapies. Different types or sources of stem cells may be
optimal for treatment of specific conditions. In order to determine the
very best source of many of the specialized cells and tissues of the body
for new treatments and even cures, it is vitally important to study the
potential of adult stem cells for comparison to that of [human
pluripotent stem cells] derived from embryos and fetuses. Unless all
stem cell types are studied, the differences between adult stem cells
and embryo and fetal-derived [human pluripotent stem cells] will not
be known.
Id. This line of reasoning could also be applied to somatic cell nuclear transfer.
188. See Branum, supra note 146, at 47.
189. See supra Part II.A.
190. See Allison C. Ayer, Comment, Stem Cell Research: The Laws of Nations
and a Proposal for International Guidelines, 17 CONN. J. INT'L L. 393, 417-18
(2002).
191. See generally 45 C.F.R. § 46.111 (2005) (providing the Institutional
Review Board informed consent protocols); 45 C.F.R. § 46.116 (2005) (reciting
the general requirements for informed consent).
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for the derivation of human pluripotent stem cells for
research. In addition, donors should also agree that their
donations are made without any restrictions regarding the
transplantation's recipient. It should also be disclosed that
there may be commercial potential in the results of the
research and that the donors will not be entitled to any
compensation.'92 Moreover, the regulation should provide
that no inducement, monetary or otherwise, has or will be
made for the donation of human tissue or embryos for
research. 193
However, unlike the NIH guidelines, the proposed federal
regulations should require that the donor's identity be
disclosed to the researchers.9 First, this will allow for an
accurate federal database of the sources of stem cells.
Second, it will allow scientists to learn more about the
sources of the embryos that they are to research. Although
this may deter individuals from donating embryos, with the
400,000 excess embryos in fertility clinics nationwide,'95 there
will likely be an ample number of willing donors available to
assist the progress of science. 196
Third, in order to ensure that the derivation of stem cells
is ethically proper, the proposed federal regulations should
require that all agencies register the stem cells on which they
are conducting research.'97 This is imperative because if stem
cells are derived from illegal sources, such as the sale of
human parts or embryos for research, the government should
be able to monitor and regulate the source of such cells.
Information in the registry should include specifics of how
192. National Institutes of Health Guidelines for Research Using Human
Pluripotent Stem Cells, 65 Fed. Reg. 51,976, 51,980 (Aug. 25, 2000).
193. See id. at 51,977.
194. See id. at 51,980. The NIH provides that "a statement as to whether or
not information that could identify the donors of the embryos, directly or
through identifiers linked to the donors, will be removed prior to the derivation
or the use of human pluripotent stem cells." Id.
195. Vergano, Embryonic Imbroglio, supra note 22, at 6D.
196. Kerstin Bjuresten & Outi Hovatta, Donation of Embryos for Stem Cell
Research-How Many Couples Consent?, 18 HUM. REPROD. 1353, 1353 (2003),
available at http://humrep.oxfordjournals.org/cgi/content/full/18/6/1353
(reporting that ninety-two percent of couples who underwent infertility
treatment in Sweden preferred donating their supernumerary embryos for stem
cell research rather than letting them be discarded).
197. See Ayer, supra note 190, at 419.
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research is conducted,'98 identification of the individuals
involved in the research protocols, and a detailed log of the
identities of the donors of the stem cells. The government
should also try to institute a national bank of stem cells,
similar to the one created in the United Kingdom, 199 that
would offer a readily available resource of stem cells for both
public and private entities.2 °0 Implementing a stem cell bank
will ensure that stem cells are derived from proper sources
and will also provide scientists with convenient access to stem
cells for research.20 1
Fourth, the guidelines should be applicable to both public
and private industries.2 °2 The purpose of the proposed federal
regulations is to set ethical and scientific guidelines for
research throughout the nation.20 3 Currently, the federal
government does not directly regulate stem cell research in
the private sector.20 4 This lack of standards or regulation
could lead to unethical practices by researchers. 20 5  Thus,
because Congress can regulate stem cell research pursuant to
the Commerce Clause, it should be able to regulate the
private stem cell industry regardless of whether it receives
federal funding.
The last section of the guidelines should address the
issue of preemption. Several states have implemented stem
cell policies 206 that may create a patchwork of policies to
which a national agency would find difficult to conform.
198. Id.
199. See Stevens, supra note 150, at 648; Stem Cell Research: Britain Opens
National Stem Cell Bank, STEM CELL WK., Jan. 17, 2005, at 26.
200. See, e.g., Suzanne Kadereit & Pamela J. Hines, An Overview of Stem
Cell Research, 39 NEW ENG. L. REV. 607, 621 (2005) ("[Cllinical application of
embryonic stem cells will require large banks of cell lines in order to provide an
immunological match for as many patients as possible.").
201. See Stem Cell Research: Britain Opens National Stem Cell Bank, supra
note 199, at 26.
202. See Sylvia Kim, Note, Embryonic Stem Cell Research Controversy: Focus
on the Private Sector and International Sphere, 14 HASTINGS WOMEN'S L.J. 89,
102-05 (2003) (explaining that regulating the private sector will allow for ethical
oversight by the federal government).
203. See THE PRESIDENT'S COUNCIL ON BIOETHICS, supra note 45, at 21-51.
204. See Kim, supra note 202, at 102 ("Because no federal regulations exist
outside of the federal funding context, privately funded researchers are
currently virtually unregulated.").
205. See Stevens, supra note 150, at 649-50.
206. See, e.g., CAL. HEALTH & SAFETY CODE § 125291.10-.85 (West Supp.
2006); N.J. STAT. ANN. § 26:2Z-2 (West Supp. 2005).
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Thus, it would be more pragmatic to have a national policy
that normalizes the regulations among the states. °
Given this ideal of a national policy, the standards set
forth in the guidelines should preempt any conflicting
regulations set forth by individual states. However, where
the federal guidelines are silent, states should be free to
maintain their current policies. Since states like California
have tried to implement policies in accordance with the
proposed national standard,2 8 the issue of preemption should
not be problematic. However, California, New Jersey, and
Massachusetts have expressly stated that they would allow
research to be conducted on stem cells produced by SCNT
technology.209 Therefore, it is important that the federal
guidelines allow this resource to be utilized in the event that
researchers in these states have already begun implementing
this means of research.
VI. CONCLUSION
The Executive Order has created a tension between the
federal government's authority to restrict funding of stem cell
research and the states' deliberate attempts to enact laws
that circumvent such limitations. 210 Nevertheless, it will be
an exciting decade for stem cell research, especially for
researchers in California. Since states are often viewed as
laboratories of experimentation, it will be interesting to see
the effects of California's Proposition 71 on stem cell research
in the United States. With several states already attempting
to pass legislation to follow California's lead, it is likely that
many other states concerned with their biotechnology
industry will press for legislative support in favor of stem cell
research. 21 1  Accordingly, it is imperative to implement a
national policy that avoids the problems associated with a
patchwork of federal and state regulations. Such a national
207. See Stevens, supra note 150, at 649.
208. California has modeled its policies in accordance with the Institutional
Review Board and National Health Institute. See CAL. HEALTH & SAFETY CODE
§§ 125291.10-.85.
209. Id. H3 125291.10-.85; N.J. STAT. ANN. § 26:2Z-2; MASS. GEN. LAWS ch.
ll1L § 1 (2005).
210. See supra Part II.C.
211. See Chase & Gorner, supra note 143, at Ml; Garvey, supra note 122, at
Al; Mansnerus, supra note 143, at B1.
448 [Vol: 46
2006] THE FATE OF STEM CELL RESEARCH 449
policy should detail the regulatory scheme for stem cell
research and set forth standards that afford scientists the
leniency required to advance this technology, while taking
into consideration the ethical and moral concerns over such
research.

